These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20462342)

  • 21. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
    Patel VB; Zhong JC; Grant MB; Oudit GY
    Circ Res; 2016 Apr; 118(8):1313-26. PubMed ID: 27081112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin-angiotensin system and diabetes: an update.
    Ribeiro-Oliveira A; Nogueira AI; Pereira RM; Boas WW; Dos Santos RA; Simões e Silva AC
    Vasc Health Risk Manag; 2008; 4(4):787-803. PubMed ID: 19065996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury.
    Varagic J; Ahmad S; Nagata S; Ferrario CM
    Curr Hypertens Rep; 2014 Mar; 16(3):420. PubMed ID: 24510672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice.
    Li Y; Wu J; He Q; Shou Z; Zhang P; Pen W; Zhu Y; Chen J
    Hypertens Res; 2009 May; 32(5):369-74. PubMed ID: 19325560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (Pro)renin receptor as a therapeutic target for the treatment of hypertension?
    Chan SH; Chan JY
    Hypertension; 2015 Feb; 65(2):278-9. PubMed ID: 25421978
    [No Abstract]   [Full Text] [Related]  

  • 27. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-(1-7) as an antihypertensive, antifibrotic target.
    Katovich MJ; Grobe JL; Raizada MK
    Curr Hypertens Rep; 2008 Jun; 10(3):227-32. PubMed ID: 18765095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
    Oudit GY; Penninger JM
    Curr Heart Fail Rep; 2011 Sep; 8(3):176-83. PubMed ID: 21611889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.
    von Lutterotti N; Catanzaro DF; Sealey JE; Laragh JH
    Circulation; 1994 Jan; 89(1):458-70. PubMed ID: 8281681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function.
    Ferrario CM; Varagic J
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1297-305. PubMed ID: 20375118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-angiotensin system revisited.
    Fyhrquist F; Saijonmaa O
    J Intern Med; 2008 Sep; 264(3):224-36. PubMed ID: 18793332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
    Patel VB; Lezutekong JN; Chen X; Oudit GY
    Can J Cardiol; 2017 Jul; 33(7):943-946. PubMed ID: 28279521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prorenin uptake in the heart: a prerequisite for local angiotensin generation?
    Jan Danser AH; Saris JJ
    J Mol Cell Cardiol; 2002 Nov; 34(11):1463-72. PubMed ID: 12431445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure.
    Aimo A; Vergaro G; Passino C; Clerico A
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):530-545. PubMed ID: 34196254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
    Soto M; diZerega G; Rodgers KE
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
    Trask AJ; Ferrario CM
    Cardiovasc Drug Rev; 2007; 25(2):162-74. PubMed ID: 17614938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.
    Lautner RQ; Villela DC; Fraga-Silva RA; Silva N; Verano-Braga T; Costa-Fraga F; Jankowski J; Jankowski V; Sousa F; Alzamora A; Soares E; Barbosa C; Kjeldsen F; Oliveira A; Braga J; Savergnini S; Maia G; Peluso AB; Passos-Silva D; Ferreira A; Alves F; Martins A; Raizada M; Paula R; Motta-Santos D; Klempin F; Pimenta A; Alenina N; Sinisterra R; Bader M; Campagnole-Santos MJ; Santos RA
    Circ Res; 2013 Apr; 112(8):1104-11. PubMed ID: 23446738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.